UC BON.CAP.CERT. 03/25 OMV/ DE000UG22931 /
1/23/2025 1:45:31 PM | Chg.+1.070 | Bid2:16:36 PM | Ask2:16:36 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
61.330EUR | +1.78% | 61.450 Bid Size: 6,000 |
61.560 Ask Size: 6,000 |
OMV AG | - - | 3/28/2025 | Call |
GlobeNewswire
3/26/2024
Intravacc announces positive data of first in human intranasal OMV based vaccine for SARS-CoV-2
GlobeNewswire
1/16/2024
Intravacc Awarded US$ 633K CARB-X Funding to Develop a Vaccine that Prevents Gonorrhea Infections
GlobeNewswire
9/14/2023
Intravacc Announces Review Publication of OMV-based Intranasal Vaccines for Disease Prevention
GlobeNewswire
12/4/2018
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center
GlobeNewswire
12/4/2018
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center